Enhanced Alzheimer’s Disease Prediction Through Integration of Protein-Protein Interaction Data and Meta-Learning
Association between proteins and diseases have been widely studied to understand disease triggers and identify potential therapeutic targets. Deciphering the complexity of gene networks is crucial for understanding diseases. Node embedding offers a powerful approach, revealing latent patterns that c...
| Published in: | IEEE Access |
|---|---|
| Main Authors: | Hansa J. Thattil, M. N. Arunkumar, Francis Antony |
| Format: | Article |
| Language: | English |
| Published: |
IEEE
2025-01-01
|
| Subjects: | |
| Online Access: | https://ieeexplore.ieee.org/document/10963671/ |
Similar Items
Microfluidic Protein Imaging Platform: Study of Tau Protein Aggregation and Alzheimer’s Drug Response
by: Shubha Jain, et al.
Published: (2020-12-01)
by: Shubha Jain, et al.
Published: (2020-12-01)
Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases
by: Mubashir Hassan, et al.
Published: (2024-05-01)
by: Mubashir Hassan, et al.
Published: (2024-05-01)
Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease
by: Georgios N. Dimitrakopoulos, et al.
Published: (2023-10-01)
by: Georgios N. Dimitrakopoulos, et al.
Published: (2023-10-01)
Protein interaction prediction for Alzheimer’s disease using a multi-source protein features fusion framework
by: Shi-Rui Yu, et al.
Published: (2025-09-01)
by: Shi-Rui Yu, et al.
Published: (2025-09-01)
Exploring shared therapeutic targets for Alzheimer’s disease and glioblastoma using network pharmacology and protein-protein interaction approach
by: Sushma Pradeep, et al.
Published: (2025-03-01)
by: Sushma Pradeep, et al.
Published: (2025-03-01)
Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.
by: Vanessa de Jesus R. de Paula, et al.
Molecular Mechanisms of Protein–Lipid Interactions and Protein Folding of Heterogeneous Amylin and Tau Oligomers on Lipid Nanodomains That Link to Alzheimer’s
by: Natalia Santos, et al.
Published: (2023-12-01)
by: Natalia Santos, et al.
Published: (2023-12-01)
A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
by: Yi Sun, et al.
Published: (2023-08-01)
by: Yi Sun, et al.
Published: (2023-08-01)
Protein Oxidation in Aging and Alzheimer’s Disease Brain
by: Rukhsana Sultana, et al.
Published: (2024-05-01)
by: Rukhsana Sultana, et al.
Published: (2024-05-01)
Novel immunological approaches for the treatment of Alzheimer's disease
by: Priyanka Sabharwal, et al.
Published: (2014-03-01)
by: Priyanka Sabharwal, et al.
Published: (2014-03-01)
Co-Deposited Proteins in Alzheimer’s Disease as a Potential Treasure Trove for Drug Repurposing
by: Avgi E. Apostolakou, et al.
Published: (2025-04-01)
by: Avgi E. Apostolakou, et al.
Published: (2025-04-01)
Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)
by: Mandić Gorana, et al.
Published: (2008-01-01)
14-3-3 proteins—a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer’s disease
by: Gholamareza Abdi, et al.
Published: (2024-02-01)
by: Gholamareza Abdi, et al.
Published: (2024-02-01)
CSF protein ratios with enhanced potential to reflect Alzheimer’s disease pathology and neurodegeneration
by: Sára Mravinacová, et al.
Published: (2024-02-01)
by: Sára Mravinacová, et al.
Published: (2024-02-01)
From Small Peptides to Large Proteins against Alzheimer’sDisease
by: Pasquale Picone, et al.
Published: (2022-09-01)
by: Pasquale Picone, et al.
Published: (2022-09-01)
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer’s disease
by: Huimin Cai, et al.
Published: (2024-03-01)
by: Huimin Cai, et al.
Published: (2024-03-01)
Hibernation Impairs Odor Discrimination – Implications for Alzheimer’s Disease
by: Torsten Bullmann, et al.
Published: (2019-07-01)
by: Torsten Bullmann, et al.
Published: (2019-07-01)
Protein kinases as therapeutic targets for Alzheimer’s disease: a brief review
by: Isabela Marie Fernandes Silva, et al.
Published: (2024-10-01)
by: Isabela Marie Fernandes Silva, et al.
Published: (2024-10-01)
Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
by: Akshatha Ganne, et al.
Published: (2022-06-01)
by: Akshatha Ganne, et al.
Published: (2022-06-01)
Emerging Function of Prolactin-Inducible Protein—Is This Important Tear Protein Found in Alzheimer’s Disease?
by: James Chmiel, et al.
Published: (2026-06-01)
by: James Chmiel, et al.
Published: (2026-06-01)
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
by: Hua Zhang, et al.
Published: (2018-08-01)
by: Hua Zhang, et al.
Published: (2018-08-01)
Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases
by: Hui-Liang Zhang, et al.
Published: (2022-06-01)
by: Hui-Liang Zhang, et al.
Published: (2022-06-01)
Growth‐Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study
by: Neda Songhori, et al.
Published: (2025-03-01)
by: Neda Songhori, et al.
Published: (2025-03-01)
The translocator protein ligands as mitochondrial functional modulators for the potential anti-Alzheimer agents
by: TaeHun Kim, et al.
Published: (2021-01-01)
by: TaeHun Kim, et al.
Published: (2021-01-01)
The Study of Interactions between Amyloid-Beta Precursor Protein and Functional Nanomotors as a New anti-Alzheimer\'s Disease Strategy by Modeling and Computer Simulation
by: Saeideh Jafarinezhad, et al.
Published: (2016-09-01)
by: Saeideh Jafarinezhad, et al.
Published: (2016-09-01)
Cross-attention PHV: Prediction of human and virus protein-protein interactions using cross-attention–based neural networks
by: Sho Tsukiyama, et al.
Published: (2022-01-01)
by: Sho Tsukiyama, et al.
Published: (2022-01-01)
Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer’s disease models: a systematic review and meta-analysis
by: Jia-Yang Liu, et al.
Published: (2024-01-01)
by: Jia-Yang Liu, et al.
Published: (2024-01-01)
Neuron modelling for Alzheimer’s neuron condition in early, intermediate, and advanced stage using amyloid-beta and tau protein as parameters
by: Jagruti Patil, et al.
Published: (2022-04-01)
by: Jagruti Patil, et al.
Published: (2022-04-01)
The role of protein phosphorylation modifications mediated by iron metabolism regulatory networks in the pathogenesis of Alzheimer’s disease
by: Fei-Xiang Liu, et al.
Published: (2025-02-01)
by: Fei-Xiang Liu, et al.
Published: (2025-02-01)
A populational review of the amyloid precursor protein gene mutations relevant to alzheimer’s disease
by: I.M. Balmus, et al.
Published: (2021-04-01)
by: I.M. Balmus, et al.
Published: (2021-04-01)
Dual-Specificity Protein Phosphatase 4 (DUSP4) Overexpression Improves Learning Behavior Selectively in Female 5xFAD Mice, and Reduces β-Amyloid Load in Males and Females
by: Allen L. Pan, et al.
Published: (2022-12-01)
by: Allen L. Pan, et al.
Published: (2022-12-01)
Much More Than a Cytoskeletal Protein: Physiological and Pathological Functions of the Non-microtubule Binding Region of Tau
by: Roland Brandt, et al.
Published: (2020-10-01)
by: Roland Brandt, et al.
Published: (2020-10-01)
Learning distributed representations of RNA and protein sequences and its application for predicting lncRNA-protein interactions
by: Hai-Cheng Yi, et al.
Published: (2020-01-01)
by: Hai-Cheng Yi, et al.
Published: (2020-01-01)
Association between dietary protein intake and risk of chronic kidney disease: a systematic review and meta-analysis
by: Yu Cheng, et al.
Published: (2024-06-01)
by: Yu Cheng, et al.
Published: (2024-06-01)
An Efficient Ensemble Approach for Alzheimer’s Disease Detection Using an Adaptive Synthetic Technique and Deep Learning
by: Muhammad Mujahid, et al.
Published: (2023-07-01)
by: Muhammad Mujahid, et al.
Published: (2023-07-01)
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
by: Min Jeong Wang, et al.
Published: (2017-12-01)
by: Min Jeong Wang, et al.
Published: (2017-12-01)
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
by: Goran Šimić, et al.
Published: (2016-01-01)
by: Goran Šimić, et al.
Published: (2016-01-01)
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
by: Irina Milisav, et al.
Published: (2015-12-01)
by: Irina Milisav, et al.
Published: (2015-12-01)
Mechanisms of electroacupuncture for improving Alzheimer’s disease from reducing β amyloid protein level
by: YANG Wen-dan, et al.
Published: (2020-01-01)
by: YANG Wen-dan, et al.
Published: (2020-01-01)
Alterations in protein phosphorylation in the amygdala of the 5XFamilial Alzheimer's disease animal model
by: Eun-Jeong Yang, et al.
Published: (2017-04-01)
by: Eun-Jeong Yang, et al.
Published: (2017-04-01)
Similar Items
-
Microfluidic Protein Imaging Platform: Study of Tau Protein Aggregation and Alzheimer’s Drug Response
by: Shubha Jain, et al.
Published: (2020-12-01) -
Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases
by: Mubashir Hassan, et al.
Published: (2024-05-01) -
Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease
by: Georgios N. Dimitrakopoulos, et al.
Published: (2023-10-01) -
Protein interaction prediction for Alzheimer’s disease using a multi-source protein features fusion framework
by: Shi-Rui Yu, et al.
Published: (2025-09-01) -
Exploring shared therapeutic targets for Alzheimer’s disease and glioblastoma using network pharmacology and protein-protein interaction approach
by: Sushma Pradeep, et al.
Published: (2025-03-01)
